# FDA recall D-1454-2019

> **InvaGen Pharmaceuticals, Inc.** · Class III · drug recall initiated 2019-06-12.

## Product

Testosterone Topical Solution 30mg of testosterone per pump actuation * each actuation delivers 1.5 mL of solution Total contents: 110 mL to deliver 90 mL, Manufactured by: Cipla Ltd, Verna Goa, India Manufactured for: Cipla USA, Inc., Sunrise, FL 33323 NDC 69097-363-44

## Reason for recall

Defective Container; actuator may improperly function and affect dose delivery.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-1454-2019
- **Recalling firm:** InvaGen Pharmaceuticals, Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2019-06-12
- **Report date:** 2019-07-10
- **Termination date:** 2021-01-28

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Central Islip, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1454-2019

## Citation

> AI Analytics. FDA recall D-1454-2019. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-1454-2019. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*